| Revenue growth | Q2 +51% YoY; H1 +47% YoY; H1 CC +38% |
|---|---|
| Margins | Adj. EBITDA margin 17% vs 11% H1 FY26; subscription GM stable 67% |
| Demand visibility | TTM new ACV +79% YoY to ₹933 Mn (excl. one healthcare deal) |
| Management confidence | On track for FY27 guidance; claims best-in-class retention |
Growth
H1 FY27 revenue +47% YoY to ₹5,280 Mn; organic +23%. H1 Adj. EBITDA +116% YoY to ₹889 Mn.
Outlook
FY27 guidance of ₹10,650 Mn revenue and ₹1,720 Mn Adj. EBITDA reiterated. Substantial migration pipeline for coming quarters.
Risks
Inorganic NRR at 94% during migrations. ₹333.9 Mn cyber-fraud loss pending insurance settlement. Kognitiv and SessionM migrations still in progress.
Investor Presentation filed with NSE, NSE: CAPILLARY. Summary written with AI assistance from the document.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹502.55
- Market cap
- ₹4,000 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 95.0×Sector 23.5×
- Promoter holding
- 47.23%-4.22% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Business Update
Capillary Technologies announced the strategic shutdown of its China operations due to low growth. Both quantitative and qualitative effects of the restructuring are stated as nil.
Capillary Technologies India Management Change
Capillary Technologies replaced internal auditor Protiviti with Deloitte Touche Tohmatsu India LLP on a 15-month term. The board cited expanding international operations as the reason.
Capillary Technologies India Other Announcement
Capillary Technologies appointed Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India. The change takes effect November 02, 2026.
Capillary Technologies India Results Update
Capillary announced Q2 FY27 revenue of ₹2,713.5 Mn (+51% YoY) and Adjusted EBITDA of ₹448.6 Mn (+103%). H1 FY27 revenue grew 47% with EBITDA up 116%.
Capillary Technologies India Merger & Restructuring
Capillary Technologies completed the deregistration of its dormant China subsidiary, Capillary Shanghai. The closure has no impact on the company's operations or financials.
Capillary Technologies India Q2 FY27 Results: Net Profit ₹21.9 Cr, Up 7200.0% YoY
Capillary Technologies India Ltd reported revenue from operations of ₹271.4 Cr (+51.4% YoY) and net profit of ₹21.9 Cr (+7200.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.9 Cr · +7200.0% YoY